Full Press Release Details
Aurora Cannabis Announces Sale of Polaris Facility
- Balance Sheet Remains Among Strongest in Industry
EDMONTON, AB, Jan. 4, 2023 /CNW/ - Aurora Cannabis
Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids
worldwide, announced today that the Company has closed the sale of its Aurora Polaris facility for gross proceeds of approximately
$15 million, previously announced to be closing under the Company's ongoing transformation program.
Aurora's balance sheet remains in a net cash position,
with approximately $320 million of cash and cash equivalents (including approximately $63 million of restricted cash) inclusive of the
transaction announced today, and the Company reiterates its expectation of achieving Adjusted EBITDA profitability for the quarter ending
Aurora is a global leader in the cannabis industry,
serving both the medical and consumer markets. Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis, dedicated to
helping people improve their lives. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler,
Being and Greybeard, as well as CBD brands, Reliva and KG7. Medical cannabis brands include MedReleaf, CanniMed, Aurora
and Whistler Medical Marijuana Co. Aurora also has a controlling interest in Bevo Farms, North America's leading supplier of propagated
agricultural plants. Driven by science and innovation, and with a focus on high-quality cannabis products, Aurora's brands continue to
break through as industry leaders in the medical, performance, wellness and adult recreational markets wherever they are launched. Learn
Forward Looking Statements
This news release includes statements containing certain "forward-looking information" within the meaning of applicable
securities law ("forward-looking statements"). Forward-looking statements are frequently characterized by words such as "plan",
"continue", "expect", "project", "intend", "believe", "anticipate", "estimate",
"may", "will", "potential", "proposed" and other similar words, or statements that certain events
or conditions "may" or "will" occur. Forward-looking statements made in this news release include, but are not limited
to, statements regarding the Company's path and timing to achieve Adjusted EBITDA profitability.
These forward-looking statements are only predictions.
Forward looking information or statements contained in this news release have been developed based on assumptions management considers
to be reasonable. Material factors or assumptions involved in developing forward-looking statements include, without limitation, publicly
available information from governmental sources as well as from market research and industry analysis and on assumptions based on data
and knowledge of this industry which the Company believes to be reasonable. Forward-looking statements are subject to a variety of risks,
uncertainties and other factors that management believes to be relevant and reasonable in the circumstances could cause actual events,
results, level of activity, performance, prospects, opportunities or achievements to differ materially from those projected in the forward-looking
statements. These risks include, but are not limited to, the ability to retain key personnel, the ability to continue investing in infrastructure
to support growth, the ability to obtain financing on acceptable terms, the continued quality of our products, customer experience and
retention, the development of third party government and non-government consumer sales channels, management's estimates of consumer demand
in Canada and in jurisdictions where the Company exports, expectations of future results and expenses, the risk of successful integration
of acquired business and operations, management's estimation that SG&A will grow only in proportion of revenue growth, the ability
to expand and maintain distribution capabilities, the impact of competition, the general impact of financial market conditions, the yield
from cannabis growing operations, product demand, changes in prices of required commodities, competition, and the possibility for changes
in laws, rules, and regulations in the industry, epidemics, pandemics or other public health crises, including the current outbreak of
COVID-19, and other risks, uncertainties and factors set out under the heading "Risk Factors" in the Company's annual information
form dated September 30, 2022 (the "AIF") and filed with Canadian securities regulators available on the Company's issuer profile
on SEDAR at www.sedar.com and filed with and available on the SEC's website at www.sec.gov. The Company cautions that the list of risks,
uncertainties and other factors described in the AIF is not exhaustive and other factors could also adversely affect its results. Readers
are urged to consider the risks, uncertainties and assumptions carefully in evaluating the forward-looking statements and are cautioned
not to place undue reliance on such information. The Company is under no obligation, and expressly disclaims any intention or obligation,
to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly
required by applicable securities law.
View original content to download multimedia:https://www.prnewswire.com/news-releases/aurora-cannabis-announces-sale-of-polaris-facility---balance-sheet-remains-among-strongest-in-industry-301712879.html
SOURCE Aurora Cannabis Inc.
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/January2023/04/c7320.html
For further information: For Media: Michelle Lefler, VP, Communications
& PR, media@auroramj.com; For Investors: ICR, Inc., Investor Relations, aurora@icrinc.com
CO: Aurora Cannabis Inc.
CNW 07:00e 04-JAN-23